-
1
-
-
0028294619
-
Paclitaxel (Taxol): A novel anticancer chemotherapeutic drug
-
1. Long, H. J. Paclitaxel (Taxol): a novel anticancer chemotherapeutic drug. Mayo Clin. Proc. 69:341-345; 1994.
-
(1994)
Mayo Clin. Proc.
, vol.69
, pp. 341-345
-
-
Long, H.J.1
-
2
-
-
0028040316
-
Cytotoxicity of Taxol in vitro against human and rat malignant brain tumors
-
2. Cahan, M. A.; Walter, K. A., Colvin, O. M.; Brem, H. Cytotoxicity of Taxol in vitro against human and rat malignant brain tumors. Cancer Chemother. Pharmacol. 33: 441-444; 1994.
-
(1994)
Cancer Chemother. Pharmacol.
, vol.33
, pp. 441-444
-
-
Cahan, M.A.1
Walter, K.A.2
Colvin, O.M.3
Brem, H.4
-
4
-
-
0027862595
-
Clinical development of Taxol
-
4. Arbuck, S. G.; Christian, M. C.; Fisherman, J. S.; Cazenave, L. A.; Sarosy, G.; Suffness, M.; Adams, J.; Canetta, R.; Cole, K. E.; Friedman, M. A. Clinical development of Taxol. Monogr Natl. Cancer Inst. 15:11-24; 1993.
-
(1993)
Monogr Natl. Cancer Inst.
, vol.15
, pp. 11-24
-
-
Arbuck, S.G.1
Christian, M.C.2
Fisherman, J.S.3
Cazenave, L.A.4
Sarosy, G.5
Suffness, M.6
Adams, J.7
Canetta, R.8
Cole, K.E.9
Friedman, M.A.10
-
5
-
-
0027950826
-
Taxol (paclitaxel): A novel anti-microtubule agent with remarkable anti-neoplastic activity
-
5. Fao, R.; Norton, L.; Seidman, A. D. Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity. Int. J. Clin. Lab. Res. 24:6-14; 1994.
-
(1994)
Int. J. Clin. Lab. Res.
, vol.24
, pp. 6-14
-
-
Fao, R.1
Norton, L.2
Seidman, A.D.3
-
6
-
-
0025326680
-
Hypersensitivity reactions from Taxol
-
6. Weiss, R. B.; Donehower, R. C.; Wiernik, P. H.; Ohnuma, T.; Gralla, R. J.; Trump, D. L.; Baker, J. R.; Van Echo, D. A.; VonHoff, D. D.; Leyland Jones, B. Hypersensitivity reactions from Taxol. J. Clin. Oncol. 8:1263-1268; 1990.
-
(1990)
J. Clin. Oncol.
, vol.8
, pp. 1263-1268
-
-
Weiss, R.B.1
Donehower, R.C.2
Wiernik, P.H.3
Ohnuma, T.4
Gralla, R.J.5
Trump, D.L.6
Baker, J.R.7
Van Echo, D.A.8
Vonhoff, D.D.9
Leyland Jones, B.10
-
7
-
-
0027055485
-
Phase II study and long term followup of patients treated with Taxol for advanced ovarian adenocarcinoma
-
7. Enzig, A. I.; Wiernik, P. H.; Sasloff, J. Garl, S.; Runowicz, C.; O'Hanlon, K. A.; Goldberg, G. Phase II study and long term followup of patients treated with Taxol for advanced ovarian adenocarcinoma. J. Clin. Oncol. 10:1748-1753; 1992.
-
(1992)
J. Clin. Oncol.
, vol.10
, pp. 1748-1753
-
-
Enzig, A.I.1
Wiernik, P.H.2
Sasloff, J.3
Garl, S.4
Runowicz, C.5
O'Hanlon, K.A.6
Goldberg, G.7
-
8
-
-
0027688126
-
Taxol: A promising new drug of the 90's
-
8. Rogers, B. B. Taxol: a promising new drug of the 90's. Oncol. Nurs. Forum 20:1483-1489; 1993.
-
(1993)
Oncol. Nurs. Forum
, vol.20
, pp. 1483-1489
-
-
Rogers, B.B.1
-
9
-
-
0027828594
-
Novel Taxol formulations. Taxol containing liposomes monogr
-
9. Straubinger, R. M.; Sharma, A.; Murray, M.; Mayhew, E. Novel Taxol formulations. Taxol containing liposomes Monogr. Natl. Cancer Inst. 15:69-78; 1993.
-
(1993)
Natl. Cancer Inst.
, vol.15
, pp. 69-78
-
-
Straubinger, R.M.1
Sharma, A.2
Murray, M.3
Mayhew, E.4
-
10
-
-
0027137936
-
Antitumor effect of Taxol-containing liposomes in a Taxol-resistant murine tumor model
-
10. Sharma, A.; Maythew, E.; Straubinger, R. M. Antitumor effect of Taxol-containing liposomes in a Taxol-resistant murine tumor model. Cancer Res. 53: 5877-5881; 1993.
-
(1993)
Cancer Res.
, vol.53
, pp. 5877-5881
-
-
Sharma, A.1
Maythew, E.2
Straubinger, R.M.3
-
11
-
-
0025611112
-
Antitumor activity of liposomal encapsulated doxorubicin in advanced breast cancer: Phase II study
-
11. Treat, A.; Greenspan, A.; Forst, D.; Sanchez, J. A.; Ferrans, V. J.; Potkul, L. A.; Woolley, P. V.; Rahman, A. Antitumor activity of liposomal encapsulated doxorubicin in advanced breast cancer: phase II study. J. Natl. Cancer Inst. 82:1706-1709; 1990.
-
(1990)
J. Natl. Cancer Inst.
, vol.82
, pp. 1706-1709
-
-
Treat, A.1
Greenspan, A.2
Forst, D.3
Sanchez, J.A.4
Ferrans, V.J.5
Potkul, L.A.6
Woolley, P.V.7
Rahman, A.8
-
12
-
-
0011871708
-
Liposomes: A kinetic study. Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol
-
12. Hwang, K. L.; Luk, K. K.; Beaumier, P. L. Liposomes: a kinetic study. Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol. Proc. Natl. Acad. Sci. USA 77:4030-4034; 1980.
-
(1980)
Proc. Natl. Acad. Sci. USA
, vol.77
, pp. 4030-4034
-
-
Hwang, K.L.1
Luk, K.K.2
Beaumier, P.L.3
-
14
-
-
0024551243
-
Liposomes with prolonged circulation times: Factors affecting uptake by reticuloendothelial and other tissues
-
14. Allen, T. M.; Hansen, C.; Rutledge, J. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim. Biophys. Acta 981:27-35; 1989.
-
(1989)
Biochim. Biophys. Acta
, vol.981
, pp. 27-35
-
-
Allen, T.M.1
Hansen, C.2
Rutledge, J.3
-
15
-
-
0026352832
-
Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy
-
15. Papahadjopoulos, D.; Allen, T. M.; Gabizon, A. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA 88:11460-11464; 1991.
-
(1991)
Proc. Natl. Acad. Sci. USA
, vol.88
, pp. 11460-11464
-
-
Papahadjopoulos, D.1
Allen, T.M.2
Gabizon, A.3
-
16
-
-
0026603586
-
Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes
-
16. Gabizon, A. A. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res. 52: 2431-2439; 1992.
-
(1992)
Cancer Res.
, vol.52
, pp. 2431-2439
-
-
Gabizon, A.A.1
-
17
-
-
0026751917
-
Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long-circulating liposomes
-
17. Vaage, J.; Mayhew, E.; Lasic, D.; Martin, F. Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long-circulating liposomes. Int. J. Cancer 51:942-948; 1992.
-
(1992)
Int. J. Cancer
, vol.51
, pp. 942-948
-
-
Vaage, J.1
Mayhew, E.2
Lasic, D.3
Martin, F.4
-
18
-
-
0018250922
-
Design of liposomes for enhanced local release of drugs by hyperthermia
-
18. Yatvin, M. B. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 202: 1290-1292; 1978.
-
(1978)
Science
, vol.202
, pp. 1290-1292
-
-
Yatvin, M.B.1
-
19
-
-
0029130453
-
Designing of heat sensitive liposomes from natural lipids for multimodality cancer therapy
-
19. Chelvi, T. P.; Ralhan, R. Designing of heat sensitive liposomes from natural lipids for multimodality cancer therapy. Int. J. Hyperthermia 11:685-695; 1995.
-
(1995)
Int. J. Hyperthermia
, vol.11
, pp. 685-695
-
-
Chelvi, T.P.1
Ralhan, R.2
-
20
-
-
0028856849
-
Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors
-
20. Chelvi, T. P.; Jain, S. K.; Ralhan, R. Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors. Oncol. Res. 7:393-398; 1995.
-
(1995)
Oncol. Res.
, vol.7
, pp. 393-398
-
-
Chelvi, T.P.1
Jain, S.K.2
Ralhan, R.3
-
21
-
-
0027161412
-
Microspheres for targeting drugs to specific body sites
-
21. Davis, S. S.; Illum, L.; Moghimi, S. M.; Daviers M. C., Porter, C. J. H.; Muir, I. S.; Brindley, A.; Christy, N. M.; Norman, M. E.; Williams, P.; Dunn, S. E. Microspheres for targeting drugs to specific body sites. J. Controlled Release 24:157-163; 1993.
-
(1993)
J. Controlled Release
, vol.24
, pp. 157-163
-
-
Davis, S.S.1
Illum, L.2
Moghimi, S.M.3
Daviers M, C.4
Porter, C.J.H.5
Muir, I.S.6
Brindley, A.7
Christy, N.M.8
Norman, M.E.9
Williams, P.10
Dunn, S.E.11
-
22
-
-
0021368395
-
The organ uptake of intravenously administered colloidal particles can be altered using a nonionic surfactant (poloxamer 338)
-
22. Illum, L.; Davis, S. S. The organ uptake of intravenously administered colloidal particles can be altered using a nonionic surfactant (poloxamer 338). FEBS Lett. 167: 79-82; 1984.
-
(1984)
FEBS Lett.
, vol.167
, pp. 79-82
-
-
Illum, L.1
Davis, S.S.2
-
23
-
-
34249762091
-
Activity and stability studies of ultrafine nanoencapsulated catalase and penicillinase
-
23. Munshi, N.; Chakravorty K.; De, T. K.; Maitra, A. N. Activity and stability studies of ultrafine nanoencapsulated catalase and penicillinase. Colloid Polym. Sci. 273: 464-472; 1995.
-
(1995)
Colloid Polym. Sci.
, vol.273
, pp. 464-472
-
-
Munshi, N.1
Chakravorty, K.2
De, T.K.3
Maitra, A.N.4
-
24
-
-
0011830663
-
Cancer incidence and mortality trends
-
24. Bite, S. Cancer incidence and mortality trends. J. Natl. Cancer Inst. 84:1862-1866; 1992.
-
(1992)
J. Natl. Cancer Inst.
, vol.84
, pp. 1862-1866
-
-
Bite, S.1
-
25
-
-
0027517847
-
Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines
-
25. Liebmann, J. E.; Cooks, J. A.; Lipschultz, C.; Teague, D.; Fisher, J.; Mitchell, J. B. Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br. J. Cancer 68:1104-1109; 1993.
-
(1993)
Br. J. Cancer
, vol.68
, pp. 1104-1109
-
-
Liebmann, J.E.1
Cooks, J.A.2
Lipschultz, C.3
Teague, D.4
Fisher, J.5
Mitchell, J.B.6
-
26
-
-
0027764256
-
Novel preparation of poly (vinylalcohol) microparticles without crosslinking agent for controlled drug delivery of proteins
-
26. Ficek, B. J.; Peppas, N. A. Novel preparation of poly (vinylalcohol) microparticles without crosslinking agent for controlled drug delivery of proteins. J. Controlled Release 27:259-264; 1993.
-
(1993)
J. Controlled Release
, vol.27
, pp. 259-264
-
-
Ficek, B.J.1
Peppas, N.A.2
-
27
-
-
0026523277
-
Intracellular targeting of antibiotics by means of biodegradable nanoparticles
-
27. Couvreur, P.; Fattal, E.; Alphandary, H.; Puisieux, F.; Andremont, A. Intracellular targeting of antibiotics by means of biodegradable nanoparticles. J. Controlled Release 19:259-268; 1992.
-
(1992)
J. Controlled Release
, vol.19
, pp. 259-268
-
-
Couvreur, P.1
Fattal, E.2
Alphandary, H.3
Puisieux, F.4
Andremont, A.5
-
28
-
-
0026586604
-
In vitro and in vivo studies of enzyme-digestible hydrogels for oral drug delivery
-
28. Shalaby, W. S. W.; Blevins, W. E.; Park, K. In vitro and in vivo studies of enzyme-digestible hydrogels for oral drug delivery. J. Controlled Release 19:131-144; 1992.
-
(1992)
J. Controlled Release
, vol.19
, pp. 131-144
-
-
Shalaby, W.S.W.1
Blevins, W.E.2
Park, K.3
-
29
-
-
0027982550
-
Pharmacokinetics in design of polymeric drug delivery systems
-
29. Hashida, M.; Takakura, Y. Pharmacokinetics in design of polymeric drug delivery systems. J. Controlled Release 31:163-171; 1994.
-
(1994)
J. Controlled Release
, vol.31
, pp. 163-171
-
-
Hashida, M.1
Takakura, Y.2
-
30
-
-
0023130497
-
Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages
-
30. Illum, L.; Jacobsen, L. O.; Muler, R. H.; Mak, E.; Davis, S. S. Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. Biomaterials 8:113-117; 1987.
-
(1987)
Biomaterials
, vol.8
, pp. 113-117
-
-
Illum, L.1
Jacobsen, L.O.2
Muler, R.H.3
Mak, E.4
Davis, S.S.5
-
31
-
-
0028293764
-
Drug release from a new family of biodegradable polyanhydrides
-
31. Shieh, L.; Tamada, J.; Tabata, Y.; Domb, A.; Langer, R. Drug release from a new family of biodegradable polyanhydrides. J. Controlled Release 29:73-82; 1994.
-
(1994)
J. Controlled Release
, vol.29
, pp. 73-82
-
-
Shieh, L.1
Tamada, J.2
Tabata, Y.3
Domb, A.4
Langer, R.5
|